taxonomy (4)
protein (28)
source (11)
structure (5)
composition (1)
disease (3)
reference (16)
site (44)
peptide (39)
- Homo sapiens (Human)
- Mus musculus (House mouse)
- Torpedo californica (Pacific electric ray)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- Adipocyte enhancer-binding protein 1 / Homo sapiens Q8IUX7
- Alpha-2-macroglobulin / Homo sapiens P01023
- Apolipoprotein d / Homo sapiens P05090
- Calumenin / Homo sapiens O43852
- CD59 glycoprotein / Homo sapiens P13987
- Clusterin / Homo sapiens P10909
- Decorin / Homo sapiens P07585
- Glycodelin-a / Homo sapiens P09466
- Glycoprotein hormones alpha chain - choriogonadotropin / Homo sapiens P01215
- Immunoglobulin heavy constant alpha 1 / Homo sapiens P01876
- Immunoglobulin heavy constant alpha 2 / Homo sapiens P01877
- Immunoglobulin j chain / Homo sapiens P01591
- Lactotransferrin / Homo sapiens P02788
- Lumican / Homo sapiens P51884
- Lutropin beta chain / Homo sapiens P01229
- Nephronectin / Homo sapiens Q6UXI9
- Olfactomedin-like protein 3 / Homo sapiens Q9NRN5
- Periostin / Homo sapiens Q15063
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Prostate-specific antigen (psa-1) / Homo sapiens P07288
- Recombinant mature angiotensin-converting enzyme 2 / Homo sapiens Q9BYF1
- Thrombospondin-1 / Homo sapiens P07996
- Uromodulin / Homo sapiens P07911
- Thy-1 membrane glycoprotein / Mus musculus P01831
- Acetylcholine receptor protein / Torpedo californica P02712 P02714 P02718 P02710
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Amniotic Fluid (UBERON_0000173)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Electric Organ (UBERON_0006869)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Pituitary Gland (UBERON_0000007)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
Source
- N-Linked / Complex / NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 2437
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-6)"
- N-Linked / Undefined core / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc + " + Hex + 3x HexNAc + NeuAc "
Reported structure
- Hex:4 HexNAc:5 NeuAc:1 (avg mass : 1973.8178 )
Composition
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC-MS/MS (2014 - Song E, Mayampurath A, Yu CY, Tang H, Mechref Y) / Status : Reviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures (2013 - Strum JS1, Nwosu CC, Hua S, Kronewitter SR, Seipert RR, Bachelor RJ, An HJ, Lebrilla CB) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. (1995 - Dell A, Morris H, Easton R, Panico M, Patankar M, Oehniger S, Koistinen R, Koistinen H, Seppala M, Clark G) / Status : Reviewed
- Detailed structural analysis of asparagine-linked oligosaccharides of the nicotinic acetylcholine receptor from Torpedo californica. (1992 - Shoji H, Takahashi N, Nomoto H, Ishikawa M, Shimada I, Arata Y, Hayashi K) / Status : Reviewed
- NMR investigations of the N-linked oligosaccharides at individual glycosylation sites of human lutropin. (1991 - Weisshaar G, Hiyama J, Renwick A, Nimtz M) / Status : Reviewed
Reference
- Adipocyte enhancer-binding protein 1 / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
- Apolipoprotein d / Homo sapiens
- Calumenin / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Clusterin / Homo sapiens
- Decorin / Homo sapiens
- Glycodelin-a / Homo sapiens
- Glycoprotein hormones alpha chain - choriogonadotropin / Homo sapiens
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin j chain / Homo sapiens
- Lactotransferrin / Homo sapiens
- Lumican / Homo sapiens
- Lutropin beta chain / Homo sapiens
- Nephronectin / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Periostin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Prostate-specific antigen (psa-1) / Homo sapiens
- Recombinant mature angiotensin-converting enzyme 2 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Uromodulin / Homo sapiens
- Thy-1 membrane glycoprotein / Mus musculus
-
Acetylcholine receptor protein / Torpedo californica
- Undefined site
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- HENNTKDNSIQHEFSLTR (18aa)
- WFSAGLASNSSWLREK (16aa)
- NYNTNITEENVQNMNNAGDK (20aa)
- NTNITEENVQNMNNAGDK (18aa)
- FSNVTWF (7aa)
- CIQANYSIMENGK (13aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- IIVPINNRENISDPTSPIR (19aa)
- FHAIHVSGTNGTKRF (15aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- TQSLLIVNNATNVVIK (16aa)
- LHINHNNLTESVGPLPK (17aa)
- LSLHRPALEDLLLGSEANLTCTLTGLR (27aa)
- LSLHRPALEDLLLGSEANLTCTLTGLR (27aa)
- NATYGYVIDDPDPDDGFNYK (20aa)
- FQFCNDPFLGVYYHKNNK (18aa)
- VCEFQFCNDPFLGVYYHKNNK (21aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFE (11aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- FHLANR (6aa)
- IGISFNSISAVDNGSIANTPHIR (23aa)
- GNGTILK (7aa)
- FLLKYNENGTIT (12aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- FPNITNLCPFGE (12aa)
- MINTSSIIEQINEQFNWVSR (20aa)
- SIGLLSPDFQEDNETEINF (19aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- CDISNSTEAGQK (12aa)
- EVNDTLLVNELK (12aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NVSDIIPR (8aa)
- GVVTDEQGIPIANATISVSGINHGVK (26aa)
- VVNSTTGPGEHIR (13aa)
- NGTHWFV (7aa)
- NGTHWFVT (8aa)
- NQTLSLFFTVLQDVPVR (17aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 1973.8178)
- Pituitary Gland (UBERON_0000007)
- Glycoprotein hormones alpha chain - choriogonadotropin / Homo sapiens
- Lutropin beta chain / Homo sapiens
-
- N-Linked / Complex (avg mass : 1973.8178)
- Prostate-specific antigen (psa-1) / Homo sapiens
-
- N-Linked / Complex (avg mass : 1973.8178)
- Electric Organ (UBERON_0006869)
-
Acetylcholine receptor protein / Torpedo californica
- Undefined site
-
- N-Linked / Complex (avg mass : 1973.8178)
- Amniotic Fluid (UBERON_0000173)
- Glycodelin-a / Homo sapiens
-
- N-Linked / Undefined core (avg mass : 1973.8178)
- HEK293 (CVCL_0045)
-
Recombinant mature angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
-
- Hex:4 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 1973.8178)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-6)"
- N-Linked / Complex / NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 2437
- N-Linked / Undefined core / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc + " + Hex + 3x HexNAc + NeuAc "
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures (2013 - Strum JS1, Nwosu CC, Hua S, Kronewitter SR, Seipert RR, Bachelor RJ, An HJ, Lebrilla CB) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Adipocyte enhancer-binding protein 1 / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
- Apolipoprotein d / Homo sapiens
- Calumenin / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Clusterin / Homo sapiens
- Decorin / Homo sapiens
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin j chain / Homo sapiens
- Lactotransferrin / Homo sapiens
- Lumican / Homo sapiens
- Nephronectin / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Periostin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Recombinant mature angiotensin-converting enzyme 2 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Uromodulin / Homo sapiens
- Thy-1 membrane glycoprotein / Mus musculus
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- HENNTKDNSIQHEFSLTR (18aa)
- WFSAGLASNSSWLREK (16aa)
- NYNTNITEENVQNMNNAGDK (20aa)
- NTNITEENVQNMNNAGDK (18aa)
- FSNVTWF (7aa)
- CIQANYSIMENGK (13aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- IIVPINNRENISDPTSPIR (19aa)
- FHAIHVSGTNGTKRF (15aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- TQSLLIVNNATNVVIK (16aa)
- LHINHNNLTESVGPLPK (17aa)
- LSLHRPALEDLLLGSEANLTCTLTGLR (27aa)
- LSLHRPALEDLLLGSEANLTCTLTGLR (27aa)
- NATYGYVIDDPDPDDGFNYK (20aa)
- FQFCNDPFLGVYYHKNNK (18aa)
- VCEFQFCNDPFLGVYYHKNNK (21aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFE (11aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- FHLANR (6aa)
- IGISFNSISAVDNGSIANTPHIR (23aa)
- GNGTILK (7aa)
- FLLKYNENGTIT (12aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- FPNITNLCPFGE (12aa)
- MINTSSIIEQINEQFNWVSR (20aa)
- SIGLLSPDFQEDNETEINF (19aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- CDISNSTEAGQK (12aa)
- EVNDTLLVNELK (12aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NVSDIIPR (8aa)
- GVVTDEQGIPIANATISVSGINHGVK (26aa)
- VVNSTTGPGEHIR (13aa)
- NGTHWFV (7aa)
- NGTHWFVT (8aa)
- NQTLSLFFTVLQDVPVR (17aa)
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
